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INTRODUCTION
Evodiamine is a bioactive component isolated from dry
unripened fruit of Evodia rutaecarpa Bentham(1). These
fruit have long been used in Chinese medical practice for
the treatments of headache, abdominal pain, dysentery,
postpartum hemorrhage and amenorrhea(1). Pharma-
cological studies demonstrated that evodiamine has a
positive inotropic action on isolated left atria of the guinea
pig(1), an antianoxic action in anoxia induced by KCN in
mice(2)and an effect of retaining the body temperature of
rats treated with chlorpromazine(3).
Adrenal medulla contains neural crest-derived chromaf-
fin cells. Therefore, the adrenal medulla is useful for
studying the mechanism of stimulus-secretion coupling
and is regarded as a model for catecholamine containing
neurons. Physiological stimulations of the adrenal medulla
such as acetylcholine cause an increase in the levels of
intracellular free Ca2+([Ca2+]i). The increase in [Ca2+]i
leads to the stimulation of catecholamine secretion(4).
However, the effects of evodiamine on the secretions of
hormones and neurotransmitters have not yet been
reported. In the present study, we examined the effect of
evodiamine on catecholamine secretion from bovine
adrenal medulla.
MATERIALS AND METHODS
Fresh bovine adrenal glands were used throughout.
The glands were perfused retrogradly(5)with a medium
consisting of (in mM : NaCl 154, KCl 5.6, CaCl2 2.2, glu-
cose 10 and Tris-HCl buffer 20 pH 7.4)saturated with 100%
O2 and maintained at 37℃. The glands were perfused at a
rate of 4 ml/min for 40 min and then stimulated by
changing to a medium containing high K+(56 mM K+ with
equimolar reduction of Na+), acetylcholine or evodiamine.
Samples of 8 ml of perfusion fluid were collected at 2 min
intervals. Catecholamine secretion was determined by
HPLC with electrochemical detection (Yanaco model L-
2000).
Evodiamine was obtained from Wako Pure Chemical
Industries (Osaka, Japan). Other chemicals used were
commercial products of reagent grade.
RESULTS
Table 1 shows the effect of evodiamine on secretion of
catecholamine from perfused bovine adrenal medulla.
Evodiamine at a concentration of 10 μM slightly, but
significantly, stimulated the secretion of catecholamine
from the adrenal medulla. This stimulatory effect of
evodiamine was observed at concentrations of more than
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1 μM (control, 24.5±2.8 μg/2 min ; 1 μM evodiamine,
27.6±2.9 μg/2 min, N=6) and continued for at least 30
min. To determine whether the stimulatory effect of
evodiamine on catecholamine secretion depends on Ca2+
in the perfusion fluid, the adrenal medulla was perfused
with Ca2+-free fluid. As shown in Table 1, the slight effect
of evodiamine on catecholamine secretion was not
observed in Ca2+-free fluid. Therefore, evodiamine may
stimulate the secretion of catecholamine through increase
in Ca2+ uptake into the cells of the adrenal medulla.
Catecholamine secretion from the adrenal medulla is
known to be induced by stimulation of acetylcholine
receptors or depolarization of the cell membrane by high
K+(6). As shown in Fig.1, the effect of evodiamine on
acetylcholine-induced catecholamine secretion from per-
fused adrenal medulla was examined. Acetylcholine
transiently increased the secretion of catecholamine from
the adrenal medulla. This catecholamine secretion was
potentiated by concentrations between 0.1 to 10 μM
evodiamine. To exclude effects of evodiamine on acetyl-
choline receptors, we examined its effects on high K+-
induced catecholamine secretion from perfused adrenal
medulla(Fig.2). High K+ also transiently increased the
secretion of catecholamine from the adrenal medulla.
Evodiamine potentiated both the amount and the duration
of catecholamine secretion induced by high K+ stimula-
tion.
There are reports that desensitization, in other words,
insensitive to catecholamine secretion produced by
frequent same stimulations, of stimulus secretion coupling
in the bovine adrenal medulla is induced by physiological
stimulations such as acetylcholine as well as high K＋(7-
10). To determine whether evodiamine influences the
process of desensitization of catecholamine secretion, we
investigated the effects of evodiamine on catecholamine
secretion after acetylcholine- or high K+-induced desensiti-
zation (Fig.3 and 4). The secretion of catecholamine was
promptly enhanced by acetylcholine or high K+, but
returned to the control level on treatment for 20 min.
When evodiamine was added to the perfusion fluid after
acetylcholine or high K+ stimulation for 10 min, the
secretion of catecholamine again increased greatly (Fig.3
and 4). Nifedipine, a typical voltage-dependent calcium
channel blocker, did not change the effect of evodiamine
on acetylcholine- or high K+-stimulated catecholamine
secretion in the same experimental protocol (Table 2).
Moreover, 12-O -tetradecanoyl phorbol 13-acetate (TPA),
Table 1. Effect of evodiamine on catecholamine secretion from
perfused bovine adrenal medulla
Adrenal medulla was stimulated by 10 μM evodiamine with or
without Ca2+ in the perfusion fluid. Catecholamine secretion was
determined as described in Materials and Methods. Data are
means±SE for 4-6 separate experiments.
*Significantly greater than control (p<0.05).
#Significantly less than with Ca2+ (p<0.01).
Fig.1. Effect of evodiamine on acetylcholine-induced catecholamine
secretion from perfused bovine adrenal medulla.
Adrenal medulla was stimulated by 100 μM acetylcholine for 10
min without evodiamine, and then stimulated again by 100 μM
acetylcholine with (hatched columns) or without (open columns)
0.1-10 μM evodiamine. Catecholamine secretion was significantly
greater with 1 and 10 μM evodiamine than without evodiamine (p<
0.01).
Catecholamine secretion was determined as described in Materials
and Methods. Data are means±SE for 4-6 separate experiments.
Fig. 2. Effect of evodiamine on high K+-induced catecholamine
secretion from perfused bovine adrenal medulla.
Adrenal medulla was stimulated by 56 mM K+ for 10 min without
evodiamine, and then stimulated again by 56 mM K+ with (hatched
columns) or without (open columns) 0.1-10 μM evodiamine.
Catecholamine secretion was significantly greater with 1 and 10 μM
evodiamine than without evodiamine (p<0.01).
Catecholamine secretion was determined as described in Materials
and Methods. Data are means±SE for 4-6 separate experiments.
Catecholamine Secretion
(μg/2 min)
2.2 mM Ca2+ 0 mM Ca2+
Control 24.5±2.8
Evodiamine(10 μM)
(0-2 min) 32.3±3.5*
(8-10 min) 37.5±4.1*
(28-30 min) 38.4±4.3*
24.3±2.2
25.2±2.9
25.1±2.6#
24.8±2.7#
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an activator of protein kinase C, did not mimic evodiamine
which enhances the secretion of catecholamine from the
bovine adrenal medulla, after stimulation by acetylcholine
or high K+ (Table 3). These results suggest that evodia-
mine may reverse the insensitivity of the bovine adrenal
medulla to induction of catecholamine secretion that
develops during acetylcholine or high K+ stimulation.
DISCUSSION
Little is known about the effects of evodiamine or
related compounds on stimulus-secretion coupling in
several hormonal organs or nervous systems. In the
present study, we demonstrated that evodiamine greatly
increased acetylcholine- or high K+-stimulated catechola-
mine secretion from the bovine adrenal medulla even after
desensitization of the response (Fig. 3 and 4), although
evodiamine alone had only a slight, but significant, effect
on the spontaneous secretion (Table 1). Therefore, it is
difficult to conclude that the effects of evodiamine and
acetylcholine or high K+ on catecholamine secretion were
simply additive. In the experimental conditions for Fig.3
and 4, we found that the stimulatory effect of evodiamine
on acetylcholine- or high K+-induced catecholamine secre-
tion was not affected by nifedipine, a typical voltage-
dependent calcium channel blocker (Table 2). Therefore,
the stimulatory effect of evodiamine on catecholamine
secretion after acetylcholine or high K+ stimulation does
not seem to be regulated by activation of voltage-
dependent calcium channels on the cell membrane.
Fig. 4. Effect of evodiamine on catecholamine secretion after
stimulation of high K+ from perfused bovine adrenal medulla.
Adrenal medulla was stimulated by 56 mM K+, and 1-10 μM
evodiamine (hatched columns) was added after this stimulation for
10 min. Catecholamine secretion was significantly greater with 0.1,
1 and 10 μM evodiamine than without evodiamine (p<0.01).
Catecholamine secretion was determined as described in Materials
and Methods. Data are means±SE for 4-6 separate experiments.
Fig. 3. Effect of evodiamine on catecholamine secretion after
stimulation of acetylcholine from perfused bovine adrenal medulla.
Adrenal medulla was stimulated by 100 μM acetylcholine, and 1-
10 μM evodiamine (hatched columns) was added after this
stimulation for 10 min. Catecholamine secretion was significantly
greater with 0.1, 1 and 10 μM evodiamine than without evodiamine
(p<0.01).
Catecholamine secretion was determined as described in Materials
and Methods. Data are means±SE for 4-6 separate experiments.
Table 2. Effects of nifedipine on evodiamine-induced catechola-
mine secretion treated with acetylcholine or high K+ from perfused
bovine adrenal medulla
Adrenal medulla was stimulated by 100 μM acetylcholine or 56
mM high K+, and then 10 μM evodiamine and/or 100 μM
nifedipine were added after this stimulation for 10 min. Catechola-
mine secretion was determined as described in Materials and
Methods. Data are means±SE for 4-6 separate experiments.
Table 3. Effects of TPA on catecholamine secretion treated with
acetylcholine or high K+ from perfused bovine adrenal medulla
Adrenal medulla was stimulated by 100 μM acetylcholine or 56 mM
high K+, and then 1 μM 12-O -tetradecanoyl phorbol 13-acetate
(TPA) was added after this stimulation for 10 min. Catecholamine
secretion was determined as described in Materials and Methods.
Data are means±SE for 4-6 separate experiments.
Catecholamine Secretion (18 to 20 min)
(μg/2 min)
Acetylcholine (100 μM)
+ Evodiamine (10 μM) 130±15
Acetylcholine (100 μM) NS
+ Evodiamine (10 μM)
+ Nifedipine (100 μM) 125±13
High K+ (56 mM)
+ Evodiamine (10 μM) 100±13
High K+ (56 mM) NS
+ Evodiamine (10 μM)
+ Nifedipine (100 μM) 110±13
Catecholamine Secretion (18 to 20 min)
(μg/2 min)
Acetylcholine (100 μM) ３０±４
Acetylcholine (100 μM) NS
+ TPA (1 μM) ３１±５
High K+ (56 mM) ３６±４
High K+ (56 mM) NS
+ TPA (1 μM) ３６±５
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Acetylcholine is known to stimulate nicotinic and
muscarinic receptors in adrenal medullary cells (11).
Activation of the nicotinic receptor induces Ca2+ influx
through the cell membrane(11,12). However, activation of
the muscarinic receptor stimulates the formation of
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol(13).
Diacylglycerol is produced concurrently with IP3 on
breakdown of phosphatidyl inositol 4,5-bisphosphate
(PIP2) by phospholipase C and is thought to activate
protein kinase C by increasing the affinity of the enzyme
for calcium(14,15). Activation of protein kinase C using
phorbol ester TPA increases secretion of catecholamine
from leaking adrenal medullary cells(16). However, TPA
did not mimic evodiamine which enhances the secretion
of catecholamine from the bovine adrenal medulla, after
stimulation by acetylcholine or high K+ (Table 3).
Therefore, the stimulatory effect of evodiamine on
catecholamine secretion after acetylcholine or high K+
stimulation may not be mediated by the activation of
protein kinase C.
We are now studying the effects of evodiamine on the
intracellular mechanisms of the catecholamine secretory
response in bovine adrenal chromaffin cells in culture.
ACKNOWLEDGMENTS
This work was supported by a grant from The
Yamamura Yuichi Memorial WAKAN-YAKU Research
Foundation, Japan.
REFERENCES
1. Shoji N, Umeyama A, Takemoto T, Kajiwara A,
Ohizumi Y : Isolation of evodiamine, a powerful
cardiotonic principle, from Evodia rutaecarpa Ben-
tham (rutaceae). J Pharm Sci 75 : 612-613, 1986
2. Yamahara J, Yamada T, Kitani T, Naitoh Y, Fujimura
H : Antianoxic action of evodiamine, an alkaloid in
Evodia rutaecarpa fruit. J Ethnopharmacol 27 : 185-
192, 1989
3. Kano Y, Zong QN, Komatsu K : Pharmacological
properties of galenical preparation. XIV. Body tem-
perature retaining effect of the Chinese traditional
medicine,“goshuyu-to" and component crude drugs.
Chem Pharm Bull Tokyo 39 : 690-692, 1991
4. Masserano JM, Vulliet PR, Tank AW, Weiner N : The
role of tyrosine hydroxylase in the regulation
of catecholamine synthesis. In ; Trendelenburg U,
Weiner N, eds. : Handbook of Experimental Pharma-
cology. Catecholamines. Springer, Berlin, 1990, pp.
427-469
5. Banks P : The release of adenosine triphosphate
catabolites during the secretion of catecholamines by
bovine adrenal medulla. Biochem J 101 : 536-541,
1966
6. Oka M, Isosaki M, Yanagihara N : Isolated bovine
adrenal medullary cells : studies on regulation of
catecholamine synthesis and release. In : Usdin E,
Kopin I J, Barchas J, eds. Catecholamines : Basic and
Clinical Frontiers. Pergamon Press, Oxford, 1979, pp
70-72
7. Douglas WW, Rubin RP : The role of calcium in the
secretory response of the adrenal medulla to
acetylcholine. J Physiol (Lond)159 : 40-57, 1961
8. Baker PF, Rink TJ : Catecholamine release from
bovine adrenal medulla in response to maintained
depolarization. J Physiol (Lond)253 : 593-620, 1975
9. Bevington A, Radda GK : Declining catecholamine
secretion in adrenal medulla on prolonged stimula-
tion with acetylcholine. Biochem Pharmacol 34 :
1497-1500, 1985
10. Marley PD, Livett BG : Effects of opioid compounds
on desensitization of the nicotinic response of
isolated bovine adrenal chromaffin cells. Biochem
Pharmacol 36 : 2937-2944, 1987
11. Oka M, Isosaki M, Watanabe J : Calcium flux and
catecholamine release in isolated bovine adrenal
medullary cells : Effects of nicotinic and muscarinic
stimulation. In : Izumi F, Oka M, Kumakura K, eds.
Advances in the biosciences. Synthesis, storage and
secretion of adrenal catecholamines. Pergamon
Press, Oxford, 1981, pp 29-36
12. Wada A, Yanagihara N, Izumi F, Sakurai S,
Kobayashi H : Trifluoperazine inhibits 45Ca2+ uptake
and catecholamine secretion and synthesis in adrenal
medullary cells. J Neurochem 40 : 481-486, 1983
13. Plevin R, Boarder MR : Stimulation of formation of
inositol phosphates in primary cultures of bovine
adrenal chromaffin cells by angiotensin II, histamine,
bradykinin and carbachol. J Neurochem 51 : 634-641,
1988
14. Nishizuka Y : The role of protein kinase C in cell
surface signal transduction and tumor promotion.
Nature (Lond)312 : 315-321, 1984
15. Houchi H, Nakanishi A, Uddin MM, Ohuchi T, Oka
M : Phorbol ester stimulates catecholamine synthe-
sis in isolated bovine adrenal medullary cells. FEBS
Lett 188 : 205-2０8, 1985
16. Knight DE, Baker PF : The phorbol ester TPA
increases the affinity of exocytosis for calcium in
leaky adrenal medullary cells. FEBS Lett 160 : 98-
100, 1983
M. Yoshizumi et al. Evodiamine Enhances Catecholamine Secretion８２
